A key component of J&J vaccine could explain link to extremely rare blood clots
A key component of J&J vaccine could explain link to extremely rare blood clots Erika Edwards © Provided by NBC News A key ingredient in Johnson & Johnson’s Covid-19 vaccine could explain the possible link between the shots and the extremely rare blood clots reported in six patients in the U.S. The technology used in the drugmaker’s vaccine, called an adenovirus, is used to prompt an immune response against the coronavirus. But some experts say that it could instead — in rare cases — prompt an immune response against certain components in the blood that cause clottin...